What is veterinary point-of-care testing (POCT)?

POCT refers to diagnostic testing performed at or near the patient, in the clinic, with results available in minutes rather than days. It enables immediate clinical decision-making for infectious disease, inflammation, endocrine, and organ-function testing.

What are the main benefits of POCT?

POCT shortens time-to-diagnosis, supports same-visit treatment decisions, improves client communication, and reduces the need for send-out lab testing. Quantitative POCT adds objective, reproducible results that a simple line-based test cannot provide.

Which technologies power veterinary POCT?

The main technologies are lateral-flow immunoassay (colloidal gold) for qualitative screening and fluorescence immunochromatography (FICT) for quantitative results read by a dedicated analyzer. FICT offers higher sensitivity and precision for monitoring.

Veterinary Point-of-Care Testing (POCT): The Complete Guide

Point-of-care testing (POCT) has transformed how veterinary medicine is practised. Where clinicians once waited hours or days for reference-laboratory results, they can now obtain diagnostic data in minutes, at the cage-side, and act on it during the same consultation. This guide explains what POCT is, the technologies behind it, and how to integrate it effectively into a veterinary practice.

What Is Veterinary Point-of-Care Testing?

Point-of-care testing refers to diagnostic testing performed at or near the patient, rather than in a central laboratory. In veterinary medicine, this typically means running a test in the clinic, the treatment room, or even the field, with results available within minutes to tens of minutes.

POCT covers a broad spectrum:

Haematology and chemistry — benchtop analyzers measuring blood cells and biochemical parameters.
Immunoassays — lateral-flow and fluorescence immunoassays detecting antigens, antibodies, hormones, and other biomarkers.
Microbiology — rapid bacterial or viral identification.
Urinalysis — dipsticks and sediment analysis.
Imaging-adjacent diagnostics — ultrasound and ECG interpreted at the bedside.

This guide focuses on the immunoassay category — the fastest-growing segment of veterinary POCT — because it delivers disease-specific answers (not just general biochemistry) in minutes.

Why POCT Matters in Veterinary Practice

Speed Enables Same-Visit Decisions

The single greatest benefit is clinical immediacy. A dog presenting with vomiting and lethargy can be tested for canine parvovirus, pancreatitis, and systemic inflammation before the owner leaves the consult room. Treatment — isolation, fluid therapy, anti-emetics — begins immediately rather than after a 24-hour laboratory delay.

Reduced Patient Stress

Small sample volumes (microlitres of whole blood or a swab) mean less invasive sampling and lower stress for feline and small-breed patients.

Better Client Communication

A quantitative result shown on a screen is a powerful communication tool. Clients understand “this number is three times normal” far more readily than “the lab will call us tomorrow.”

Earlier Intervention

Many POCT biomarkers detect disease before clinical signs are advanced. SDMA, for example, rises earlier than creatinine in chronic kidney disease, enabling treatment during a window when renal function can still be preserved.

The Core Technologies

Lateral-Flow Immunoassay (LFA)

The classic rapid test format. A sample migrates along a membrane, and the presence of analyte produces a visible line. Colloidal gold is the most common visual label.

Strengths: inexpensive, instrument-free, simple. Limitations: qualitative (positive/negative), subjective interpretation, limited sensitivity.

Fluorescence Immunochromatography (FICA / FICT)

A lateral-flow test that uses a fluorescent label instead of gold. A reader excites the fluorophore and measures signal intensity, producing a quantitative concentration.

Strengths: quantitative, highly sensitive, objective, wide dynamic range, digital results. Limitations: requires a reader instrument; higher equipment cost.

FICA is the technology that has elevated veterinary rapid testing from screening to true quantitative diagnostics. For a deep technical dive, see What is Fluorescence Immunochromatography (FICA)?.

Enzyme-Linked Immunosorbent Assay (ELISA)

A laboratory technique offering high sensitivity and throughput, but requiring more time, equipment, and skilled handling. Often used as a reference method or for batch testing.

Polymerase Chain Reaction (PCR)

The gold standard for pathogen nucleic-acid detection — highly sensitive and specific, but slower, more expensive, and laboratory-bound. PCR is complementary to POCT: POCT screens rapidly at the bedside, PCR confirms and characterises.

Method	Result type	Time	Sensitivity	Where
Colloidal-gold LFA	Qualitative	5–15 min	Moderate	Cage-side
Fluorescence immunoassay (FICA)	Quantitative	10–20 min	High	Cage-side
ELISA	Quantitative	1–4 h	High	Laboratory
PCR	Qualitative/quantitative	2–6 h	Very high	Laboratory

Building a POCT Workflow

1. Define Your Testing Needs

Start with your caseload. A feline-focused clinic may prioritise FeLV/FIV, FPV, and thyroid assays. A breeding-focused practice may prioritise progesterone and relaxin. A mixed practice needs infectious-disease panels plus organ-function markers.

2. Choose the Right Platform

Match the analyzer to your throughput. A single-channel analyzer (such as the Migibio FIA680) suits low-to-moderate volume; a multi-channel analyzer (such as the FIA880) suits high-volume hospitals and reference practices. See How to Choose a Veterinary Immunofluorescence Analyzer.

3. Standardise Sampling

Consistency in sample type (serum vs. plasma vs. whole blood vs. swab), volume, and handling is essential for reliable results. Follow the manufacturer’s instructions for use (IFU) precisely.

4. Implement Quality Control

Run built-in controls with every strip, respect storage conditions and expiry dates, and run external controls periodically. Document everything. See Veterinary Laboratory Quality Control.

5. Interpret in Clinical Context

No test result stands alone. A quantitative value must be interpreted against the species-specific reference interval and the patient’s clinical picture. Trend monitoring — repeating a test over time — is often more informative than a single value.

The Role of Quantitative Biomarkers

Modern POCT goes beyond “is it infected?” to “how is the patient functioning?” Quantitative biomarkers now routinely measured at the point of care include:

SDMA and cystatin C — renal function.
NT-proBNP — cardiac stress and failure.
Pancreatic lipase (fPL/cPL) — pancreatitis.
CRP and SAA — systemic inflammation.
T4 and TSH — thyroid function.
Progesterone and relaxin — reproductive management.

For a deeper exploration, see Veterinary Biomarker Monitoring: Kidney, Cardiac, and More.

Limitations to Understand

POCT is powerful but not infallible. Clinicians should understand its boundaries:

Sensitivity vs. specificity trade-offs — no test is perfect; false positives and negatives occur.
Cross-reactivity — closely related pathogens may cross-react.
Window periods — a recently exposed animal may test negative before the analyte is detectable.
Operator error — technique and timing matter.
Storage sensitivity — reagents degrade if not stored correctly.

Conclusion

Veterinary point-of-care testing has moved from convenience to clinical necessity. Fluorescence immunoassay technology, in particular, has brought laboratory-grade quantitative accuracy to the cage-side. By selecting the right platform, standardising workflows, and interpreting results in clinical context, veterinary teams can diagnose faster, treat earlier, and communicate more effectively with clients.